Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism
Journal of Inherited Metabolic Disease · 2026
DOI: 10.1002/jimd.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Timo Keskinen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Hyperoxaluria, Primary, Transaminases, Oxalates, Gene Editing. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland Centre of Excellence on Stem Cell Metabolism, Lastentautien Tutkimussäätiö, Paulon Säätiö.
Abstract (Originalsprache)
Our research aimed to model primary hyperoxaluria type 1 in vitro using a stem cell model and assess the potential of adenine base editors in correcting the most common pathogenic AGXT genetic variant, c.508G>A (Gly170Arg), which leads to oxalate accumulation due to alanine‐glyoxylate aminotransferase mislocalization. Patient‐derived fibroblasts were induced to pluripotent stem cells, genetically corrected with adenine base editing, and subsequently differentiated into hepatocyte‐like cells in parallel with their non‐corrected isogenic counterparts. Enzyme localization was assessed through immunocytochemistry and confocal microscopy. The key metabolites associated with the disease were analyzed using liquid chromatography‐mass spectrometry to evaluate the metabolic phenotype. Finally, lipid nanoparticle formulations were designed and tested as an in vivo‐applicable delivery method for base editors. All induced pluripotent stem cell lines successfully differentiated into hepatocyte‐like cells and expressed essential hepatocyte markers, including ALB, HNF1A , and AGXT . Adenine base editor‐mediated genetic correction of the pathogenic AGXT mutation restored enzyme localization into peroxisomes and diminished oxalate accumulation without significant off‐target effects. Base editor mRNA and AGXT variant targeting single guide RNA encapsulated within lipid nanoparticles mediated gene correction in the hepatocyte‐like cell model. Using an in vitro model of primary hyperoxaluria type 1, we showed that base editor‐mediated genetic correction of the most common hyperoxaluria‐causing variant corrects enzyme mislocalization from mitochondria to peroxisomes and improves metabolic function. These results propose gene correction as a potential therapeutic approach to hyperoxaluria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
- Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
- Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.
- New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.
ORCID-Profile: Ville Hietakangas, Mervi E Hyvönen
Förderung
- Academy of Finland Centre of Excellence on Stem Cell Metabolism
- Lastentautien Tutkimussäätiö
- Paulon Säätiö
- Magnus Ehrnroothin Säätiö
- Research Council of Finland
- Novo Nordisk Fonden
- Orionin Tutkimussäätiö
- Helsinki University Hospital Research funds
Zitieren
APA
Keskinen, T., Jalil, S., Gümüşoğlu, I., Juutila, J., Kestilä, N., Kuuluvainen, E., Hietakangas, V., Balboa, D., Wartiovaara, K., & Hyvönen, M. E. (2026). Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70122
Vancouver
Keskinen T, Jalil S, Gümüşoğlu I, Juutila J, Kestilä N, Kuuluvainen E, et al. Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70122
BibTeX
@article{Keskinen2026,
author = {Keskinen, Timo and Jalil, Sami and Gümüşoğlu, Irem and Juutila, Juhana and Kestilä, Nadim and Kuuluvainen, Emilia and Hietakangas, Ville and Balboa, Diego and Wartiovaara, Kirmo and Hyvönen, Mervi E},
title = {Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
doi = {10.1002/jimd.70122}
}
EUVIMED